Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury

Feb 10, 2010

Scott & White Memorial Hospital vascular surgeons Clifford Buckley, M.D., and Ruth Bush, M.D., performed one of the nation's first implants of a Next Generation Conformable GORE TAG Thoracic Endoprosthesis device for the treatment of a traumatic aortic transection as part of a national clinical trial. The goal of the trial is to gain insight into using thoracic endografts for patients with traumatic aortic transection (tear) as a less invasive alternative to major surgery.

"This is the first time this procedure has been performed on a human as part of a landmark study and is the first device being studied for traumatic aortic transection specifically," said Dr. Buckley, a professor of surgery at Texas A&M Health Science Center College of Medicine. "Because Scott & White Memorial Hospital is the only designated Level I trauma center between Dallas and Austin, TX, we're able to provide such cutting-edge care for patients with these traumatic injuries."

Traumatic thoracic aortic transections often result in death and injury to the thoracic from motor vehicle
accidents which account for up to 15 percent of all deaths. Patients who survive usually have small tears or partial thickness tears of the aortic wall and the aorta is at greatest risk in front or side impacts. Most blunt aortic injuries occur in the proximal thoracic aorta, although any portion of the aorta is at risk. The proximal descending aorta is at greatest risk from the shearing forces of sudden deceleration.

"Trauma patients with thoracic aortic transections often have multiple, complex injuries that increase the risk of standard surgical repair of the aorta," said Dr. Bush who is also assistant dean of graduate medical education at Texas A&M Health Science Center College of Medicine. "So, a minimally-invasive treatment option like this could provide an opportunity to care for patients who might otherwise be too sick or have injuries too serious to undergo a major operation to gain access to the aorta that often requires stopping the heart."

Endovascular procedures are less invasive than major "open" surgery and involve sealing off an aneurysm by placing the endovascular graft inside the aorta, re-lining and making a new path for blood flow. The GORE TAG thoracic endograft remains inside the aorta permanently through the use of a metal stent creating a tight fit and seal against the wall of the aorta. Endovascular repair may be performed under general, regional or local anesthesia and the procedure typically takes one to three hours. Patients commonly return to normal activity within two to six weeks after the procedure.

Dr. Clifford Buckley and colleagues were the first in Central Texas to use the Conformable GORE TAG thoracic endograft that helps reinforce the weakened aortic wall. A Level 1 trauma center is a comprehensive trauma facility, and provides the highest level of specialty care available, which meets stringent national standards of performance. Access to a comprehensive trauma center and its capability to provide definitive care for every aspect of injury is strongly associated with improving a critically-injured patient's chance of survival.

Explore further: Continued reliance on Windows XP in physician practices may threaten data security

Provided by Scott & White Healthcare

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Traumatic aortic injury -- New Review

Oct 15, 2008

A blunt traumatic injury to the aorta, the body's main artery, is one of the leading causes of death following a vehicle crash. If it is not treated rapidly, the patient is at serious risk for artery rupture, which is nearly ...

Stent grafts: a better way to treat blunt trauma injuries

Aug 05, 2008

Endovascular repair—fixing an injury in a blood vessel from inside that vessel—is a better option for individuals who receive highly lethal injuries from high-speed collisions or falls (together referred to as blunt ...

Body's own veins provide superior material for aortic grafts

Dec 30, 2009

A vascular surgical technique pioneered at UT Southwestern Medical Center and designed to replace infected aortic grafts with the body's own veins has proved more durable and less prone to new infection than similar procedures ...

Recommended for you

What are the chances that your dad isn't your dad?

14 hours ago

How confident are you that the man you call dad is really your biological father? If you believe some of the most commonly-quoted figures, you could be forgiven for not being very confident at all. But how ...

New technology that is revealing the science of chewing

Apr 15, 2014

CSIRO's 3D mastication modelling, demonstrated for the first time in Melbourne today, is starting to provide researchers with new understanding of how to reduce salt, sugar and fat in food products, as well ...

After skin cancer, removable model replaces real ear

Apr 11, 2014

(HealthDay)—During his 10-year struggle with basal cell carcinoma, Henry Fiorentini emerged minus his right ear, and minus the hearing that goes with it. The good news: Today, the 56-year-old IT programmer ...

Italy scraps ban on donor-assisted reproduction

Apr 09, 2014

Italy's Constitutional Court on Wednesday struck down a Catholic Church-backed ban against assisted reproduction with sperm or egg donors that has forced thousands of sterile couples to seek help abroad.

User comments : 0

More news stories

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

How kids' brain structures grow as memory develops

Our ability to store memories improves during childhood, associated with structural changes in the hippocampus and its connections with prefrontal and parietal cortices. New research from UC Davis is exploring ...

Ebola virus in Africa outbreak is a new strain

The Ebola virus that has killed scores of people in Guinea this year is a new strain—evidence that the disease did not spread there from outbreaks in some other African nations, scientists report.